IHT Wealth Management LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

IHT Wealth Management LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 509 shares of the company’s stock, valued at approximately $207,000.

Other hedge funds also recently bought and sold shares of the company. FMR LLC grew its position in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $131,527,000. Darsana Capital Partners LP grew its holdings in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares in the last quarter. Holocene Advisors LP lifted its position in HCA Healthcare by 210.6% during the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after purchasing an additional 208,015 shares during the last quarter. Finally, Argent Capital Management LLC increased its holdings in shares of HCA Healthcare by 1,215.6% in the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock worth $51,493,000 after buying an additional 148,092 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on HCA shares. Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $380.29.

HCA Healthcare Trading Down 0.5 %

NYSE:HCA opened at $316.78 on Wednesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12 month low of $255.73 and a 12 month high of $417.14. The company has a 50-day moving average price of $362.09 and a 200-day moving average price of $358.91. The stock has a market cap of $80.24 billion, a price-to-earnings ratio of 14.22, a P/E/G ratio of 1.23 and a beta of 1.63.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.